Clinical Evaluation and Comparison of the Tecnis Symfony Optiblue and Tecnis Symfony IOLs

NCT06567834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-08-23

No results posted yet for this study

Summary

The goal of this clinical study is to compare the Tecnis Symfony Optiblue intraocular lens implant to the Tecnis Symfony intraocular lens implant in patients over 22 years old with cataracts in both eyes. The main questions it aims to answer are:

Which lens has less nighttime side effects? Which lens has higher patient satisfaction?

Participants will undergo a minimum of 7 study visits where they will complete a variety of vision tests and vision questionnaires.

Conditions

Interventions

DEVICE

Tecnis Symfony Optiblue/Tecnis Symfony Optiblue Toric (Models ZXR00V/ZXW150)

Multifocal IOL with violet light filtration and high-resolution lathing

DEVICE

Tecnis Symfony/Tecnis Symfony Toric (Models ZXR00/ZXT150)

Multifocal IOL with ultraviolet filtration

Sponsors & Collaborators

  • Johnson & Johnson Surgical Vision, Inc.

    collaborator INDUSTRY
  • Empire Eye and Laser Center

    lead OTHER

Principal Investigators

  • Daniel H Chang, MD · Empire Eye and Laser Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2023-03-09
Completion
2023-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06567834 on ClinicalTrials.gov